SHOOK DAVID (Chief Medical Officer) sold 8.6% of their position (1.98K shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $25.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/11/2026ACC: 0001959742-26-000002
Officer· Chief Medical Officer
Since Feb 2026
-1.98K
Net shares
Net seller
$25.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.98K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.98K
Price / share
$12.64
Trade value
$24.99K
% of position
8.6%
6/10/2026
22.90K→20.92K
Total
Net shares
−1.98K
Net value
-$24.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2026 | S · Sale | −1.98K | $12.64 | $24.99K | 8.6% | 22.90K | 20.92K |
| Total | −1.98K | -$24.99K | ||||||
Derivative Transactions0
No derivative transactions reported